Get the Stockscreener App
95.75
2.27%
-2.22
Pre-market:
95.19
-0.56
-0.58%
Zimmer Biomet Holdings Inc stock is traded at $95.75, with a volume of 1.76M.
It is down -2.27% in the last 24 hours and up +8.70% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$97.97
Open:
$97.97
24h Volume:
1.76M
Relative Volume:
0.82
Market Cap:
$18.73B
Revenue:
$8.01B
Net Income/Loss:
$807.20M
P/E Ratio:
23.69
EPS:
4.0411
Net Cash Flow:
$1.13B
1W Performance:
-4.11%
1M Performance:
+8.70%
6M Performance:
-8.60%
1Y Performance:
-7.92%
1-Day Range:
$95.39
$97.97
1-Week Range:
$95.39
$101.49
52-Week Range:
$84.59
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.75 | 19.17B | 8.01B | 807.20M | 1.13B | 4.0411 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-20-26 | Initiated | William Blair | Mkt Perform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
CHF67.50 pre-market 05 Mar 2026: ZBH.SW Zimmer Biomet volume spike signals test - Meyka
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Short Interest Update - MarketBeat
Zimmer Biomet (ZBH) Valuation Check As AAOS 2026 Robotics And Smart Implant Showcase Nears - simplywall.st
Victory Capital Management Inc. Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Growth with a Potential 4.28% Upside - DirectorsTalk Interviews
Mitsubishi UFJ Asset Management Co. Ltd. Buys 22,992 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Citigroup Inc. Reduces Stake in Zimmer Biomet Holdings - National Today
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Citigroup Inc. - MarketBeat
American Century Companies Inc. Sells 532,674 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet’s Robotics and Smart Knee Push Might Change The Case For Investing In ZBH - Sahm
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet’s ROSA Knee v1.5 Pilot Study: What the Latest Update Signals for ZBH Investors - TipRanks
ZBH Should I Buy - Intellectia AI
Pre-market top loser ZBH.SW Zimmer Biomet -4.26% on 27 Feb 2026: support CHF67.50 - Meyka
Primecap Management Co. CA Trims Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
HighTower Advisors LLC Sells 15,738 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins - Yahoo Finance
Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event - simplywall.st
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting - PR Newswire
Magellan Asset Management Ltd Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) officer granted 10,076 restricted stock units vesting from 2027 - Stock Titan
Zimmer Biomet (NYSE: ZBH) officer granted 9,818 RSUs, with shares withheld for taxes - Stock Titan
[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity - Stock Titan
ZBH.SW Zimmer Biomet (SIX) at CHF75.00 24 Feb 2026: volume spike tests resistance - Meyka
JPMorgan Chase & Co. Decreases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to Issue Quarterly Dividend of $0.24 - MarketBeat
Zimmer Biomet (NYSE: ZBH) executive earns 4,843 performance-based RSUs - Stock Titan
ZIMMER BIOMET (ZBH) CEO earns 24,436 performance-based RSUs vesting in 2026 - Stock Titan
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 3.95% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026, Payable on or About April 30, 2026 - marketscreener.com
Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable April 30 to Holders of Record as of March 31 - marketscreener.com
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 (2026-02-23) - Seeking Alpha
Hagens Berman Investigates Zimmer Biomet Over Alleged Emerging Market Failures - National Today
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by AMG National Trust Bank - MarketBeat
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
Zimmer Biomet’s New Stemless Shoulder Study Signals Strategic Push in Joint Reconstruction - The Globe and Mail
Vanguard Group Inc. Acquires 39,929 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $6.12 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
William Blair Initiates Zimmer Biomet Holdings at Market Perform - marketscreener.com
William Blair initiates Zimmer Biomet stock rating at Market Perform - Investing.com
ZIMMER BIOMET HOLDINGS, INC. SEC 10-K Report - TradingView
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead - Finviz
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZB - GuruFocus
Zimmer Biomet Launches Advancement for Hindfoot Fusion - Ortho Spine News
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution - marketscreener.com
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid US sales force overhaul and innovation cycle - MSN
Zimmer Biomet, Paragon 28 announce commercial launch of curved TTC nail system - MassDevice
The Top 5 Analyst Questions From Zimmer Biomet's Q4 Earnings Call - Finviz
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):